Intimation of the Pronouncement by Hon''ble NCLT, Hyderabad Bench approving Composite Scheme of amalgamation
VIYASH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.9 pts more than Nifty Microcap 250 and 2.2 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The Hon'ble NCLT, Hyderabad Bench has pronounced approval of the Composite Scheme of Amalgamation involving Viyash Scientific Limited. This is a key regulatory milestone that brings the amalgamation closer to becoming effective. The next steps typically include filing the NCLT order with the Registrar of Companies (MCA) and obtaining other statutory approvals. Shareholders of the company will be impacted as per the swap ratio and structure defined in the approved scheme. The detailed order and effective date are expected to be communicated in subsequent filings.
Near-term positive sentiment as NCLT approval removes a major regulatory hurdle; shareholders await the swap ratio details and effective date announcement, which could influence share price and shareholding structure.